Anthem Biosciences Ltd
As of 20 Nov 2026, Anthem Biosciences is in Stage 3, the topping phase, now in week 2 (since 11 Nov 2026). It closed at ₹951, 0.7% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.
Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. More about the company
Pro read
ProANTHEM's uptrend is tiring: 2 weeks into a top. A topping stock either breaks back out or rolls over into a decline, and the next few weeks usually settle which.
Its relative strength is 86 of 99, a leader among NSE stocks over the past year. Biotechnology ranks 11 of 106 industries by the strength of its stocks, among the leaders.
Is ANTHEM early, or has it already run? Pro answers that for every NSE stock, after every close.
ANTHEM among Biotechnology3rd of 9 by relative strength
All 9 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | ACUTAAS | Stage 2 · wk 3 | 96 | +21.6% |
| 2 | SAILIFE | Stage 2 · wk 37 | 96 | +29.2% |
| 3 | ANTHEM | Stage 3 · wk 2 | 86 | +18.1% |
| 4 | HESTERBIO | Stage 3 · wk 7 | 86 | +7.4% |
| 5 | 3BBLACKBIO | Stage 2 · wk 7 | 61 | −1.0% |
| 6 | ONESOURCE | Stage 1 · wk 1 | 58 | +18.6% |
| 7 | BIOCON | Stage 4 · wk 5 | 50 | +8.8% |
| 8 | PANACEABIO | Stage 4 · wk 8 | 45 | −1.0% |
Mutual fund holdings
Held by 75 mutual funds in portfolios to October 2026: 29 active funds and 46 index funds and ETFs.
In October, among active funds: 7 increased, 1 opened a new position and 5 exited.
All 75 funds, the 5 that exited, and what each did in October
Mutual funds holding ANTHEM: the ten largest and the month’s moves →
Anthem Biosciences: quick answers
What stage is Anthem Biosciences in?
As of 20 Nov 2026, Anthem Biosciences (ANTHEM) is in Stage 3, the topping phase. It entered Stage 3 on 11 Nov 2026 and is in week 2. What the four stages mean
Is Anthem Biosciences in an uptrend?
Its uptrend has stalled. Anthem Biosciences is in Stage 3, the topping phase that follows an advance. It trades 20.7% above its 200-day average, which is rising.
How far is Anthem Biosciences from its 52-week high?
Anthem Biosciences closed at ₹951 on 20 Nov 2026, 0.7% below its 52-week high of ₹958. Its 52-week low is ₹588.
How has Anthem Biosciences performed over the past year?
As of 20 Nov 2026, Anthem Biosciences is up 36.2% over the past year and up 46.0% so far in 2026.
Which sector and industry is Anthem Biosciences in?
Anthem Biosciences is in the Biotechnology industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Health Care
About this companyHealth Care· Biotechnology
Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial manufacturing of RNA-based therapies, antibody-drug conjugates, peptides and oligonucleotides, lipids, biologics and biotherapeutics, fermentation, biosynthesis and biotransformation, and flow chemistry. It also manufactures and sells complex specialized fermentation-based active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2; microbial and mammalian biosimilars; probiotics, such as bacillus species, lactobacillus species, bifidobacterium species, streptococcus species and saccharomyces boulardii; enzymes; peptides, including semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide; nutritional actives, vitamin analogues, and APIs. The company was incorporated in 2006 and is based in Bengaluru, India.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.